Craft
  • Home
  •  / Oblique Therapeutics
Oblique Therapeutics

Oblique Therapeutics

Total Funding

$2.5 M

Oblique Therapeutics Summary

Company summary

Overview
Oblique Therapeutics is a biotech company that develops medicines for severe diseases with a focus on pain and cancer. It uses Abiprot, an antibody platform that generates antibodies with programmed function against the full human proteome.
Type
Private
Status
Active
Founded
2015
HQ
Göteborg, SE | view all locations
Website
https://obliquet.com/
Cybersecurity rating
Sectors

Key people

  • Hans-Peter Ostler
  • Lars Molinder

    Lars Molinder, Board Member

    • Lotta Ostler

      Lotta Ostler, Chief Operating Officer

    • Mats Jonasson

      Mats Jonasson, Chief Financial Officer (CFO)

    LocationsView all

    2 locations detected

    • Göteborg, Västra Götalands län HQ

      Sweden

      Arvid Wallgrens backe 20

    • Stockholm, Stockholms län

      Sweden

      Döbelnsgatan 64

    Footer menu